Plain-English translation of NCT07146854 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a tracking study for patients with end-stage kidney disease who need hemodialysis. You would receive a vascular access graft (a tube that connects an artery to a vein in your upper arm) that uses the EndoForce Connector to join the graft to your vein. The study collects safety and performance information over time to make sure this approved medical device continues to work well.
The EndoForce Connector is already FDA-approved, but doctors want to gather more real-world information about how well it works and whether any safety concerns develop over the long term in patients like you.
You likely qualify if…
You likely don't qualify if…
You would have the EndoForce graft connector surgically placed in your upper arm as part of your standard kidney disease care. After that, you would attend regular follow-up visits with your healthcare team so they can monitor how the graft is working and check for any safety concerns. The study lasts long-term, meaning your medical information will continue to be collected during your regular dialysis treatments and checkups.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
United States
Enrollment target
~150 participants
Started
January 2026
Primary completion
December 2029
Age range
18 Years and older
Last updated on clinicaltrials.gov in January 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
John Zentgraf
Spartanburg Regional Medical Center
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.